The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $692,881 in first-year total cost, median $346,441.
Most frequent study sections
- Special Emphasis Panel[ZDA1 IXR-Q (09)]2
Most frequent institutions
- UNIVERSITY OF CALIFORNIA AT DAVIS1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | KCa2 Channel Activators for Opioid Use Disorder1R21DA056637-01 | WULFF, HEIKE | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $419,881 | ZDA1 |
| 2022 | Recruiting active expiration to overcome opioid-induced persistent apnea1R21DA056740-01 | FELDMAN, JACK L | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $273,000 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.